Clinical Trial Update: A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating two doses of risperidone for safety and effectiveness in children and adolescents with autism spectrum disorder; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Autistic Disorder, Autism | Phase 4 | Status: COMPLETED | Results posted: 2010-09-28